These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10720296)

  • 1. Topiramate therapy of epilepsy associated with Angelman's syndrome.
    Franz DN; Glauser TA; Tudor C; Williams S
    Neurology; 2000 Mar; 54(5):1185-8. PubMed ID: 10720296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral markers of the gamma-aminobutyric acid (GABA)ergic system in Angelman's syndrome.
    Borgatti R; Piccinelli P; Passoni D; Romeo A; Viri M; Musumeci SA; Elia M; Cogliati T; Valseriati D; Grasso R; Raggi ME; Ferrarese C
    J Child Neurol; 2003 Jan; 18(1):21-5. PubMed ID: 12661934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate for intractable childhood epilepsy.
    Moreland EC; Griesemer DA; Holden KR
    Seizure; 1999 Feb; 8(1):38-40. PubMed ID: 10091847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate: potential trade-offs between efficacy and tolerability in the treatment of epilepsy.
    Harvey AS
    J Paediatr Child Health; 2003 Aug; 39(6):414-5. PubMed ID: 12919492
    [No Abstract]   [Full Text] [Related]  

  • 5. Topiramate: new indication. A bulkier assessment file.
    Prescrire Int; 1999 Oct; 8(43):141-2. PubMed ID: 11503838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of topiramate for intractable epileptic spasms in children with symptomatic epilepsy].
    Kobayashi Y; Ishikawa N; Fujii Y
    No To Hattatsu; 2015 Jul; 47(4):310-2. PubMed ID: 26353455
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study.
    Grosso S; Franzoni E; Iannetti P; Incorpora G; Cardinali C; Toldo I; Verrotti A; Caterina Moscano F; Lo Faro V; Mazzone L; Zamponi N; Boniver C; Spalice A; Parisi P; Morgese G; Balestri P
    J Child Neurol; 2005 Nov; 20(11):893-7. PubMed ID: 16417859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Compared clinical study on treatment of childhood epilepsy with different escalating dosage protocol of topiramate].
    Huang SP; He GZ; Chen ZQ; He J
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):230-2. PubMed ID: 14756968
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of topiramate on intractable seizures in Taiwanese children.
    Li ST; Shen EY; Chiu NC; Ho CS
    Acta Neurol Taiwan; 2004 Jun; 13(2):59-63. PubMed ID: 15478676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topiramate on cognition.
    Meador KJ
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):134-5. PubMed ID: 11439970
    [No Abstract]   [Full Text] [Related]  

  • 11. [The efficacy of topiramate (topamax) in the treatment of resistant epilepsy in children].
    Dorofeeva MIu; Ermakov AIu; Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(11):21-3. PubMed ID: 16329630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
    Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T
    J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
    Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
    Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of high resolution cytogenetics, fluorescence in situ hybridisation, and DNA studies to validate the diagnosis of Prader-Willi and Angelman's syndromes.
    Smith A; Prasad M; Deng ZM; Robson L; Woodage T; Trent RJ
    Arch Dis Child; 1995 May; 72(5):397-402. PubMed ID: 7618904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of topiramate.
    Bourgeois BF
    J Child Neurol; 2000; 15 Suppl 1():S27-30. PubMed ID: 11218054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome.
    Morimoto M; Shimakawa S; Hashimoto T; Kitaoka T; Kyotani S
    J Clin Pharm Ther; 2018 Aug; 43(4):571-573. PubMed ID: 29265387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate and metabolic acidosis.
    Wilner A; Raymond K; Pollard R
    Epilepsia; 1999 Jun; 40(6):792-5. PubMed ID: 10368081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment retention with topiramate.
    Deckers CL; Renier WO
    Epilepsia; 2001 Feb; 42(2):290-1. PubMed ID: 11240609
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital.
    Wang YY; Wang MG; Yao D; Huang XX; Zhang T; Deng XQ
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):993-7. PubMed ID: 27010160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate in childhood epilepsy: past, present, and future.
    Gilman J; Duchowny PM
    J Child Neurol; 2000; 15 Suppl 1():S1-2. PubMed ID: 11218051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.